Skip to main content
Netherlands Heart Journal logoLink to Netherlands Heart Journal
editorial
. 2005 Aug;13(7-8):251–253.

GIK in acute myocardial infarction: lessons from CREATE-ECLA, GIPS II and DIGAMI 2

ICC van der Horst, F Zijlstra
PMCID: PMC2497250  PMID: 25696504

Full text

PDF
251

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ceremuzyński L., Budaj A., Czepiel A., Burzykowski T., Achremczyk P., Smielak-Korombel W., Maciejewicz J., Dziubińska J., Nartowicz E., Kawka-Urbanek T. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther. 1999 May;13(3):191–200. doi: 10.1023/a:1007787924085. [DOI] [PubMed] [Google Scholar]
  2. Díaz R., Paolasso E. A., Piegas L. S., Tajer C. D., Moreno M. G., Corvalán R., Isea J. E., Romero G. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group. Circulation. 1998 Nov 24;98(21):2227–2234. doi: 10.1161/01.cir.98.21.2227. [DOI] [PubMed] [Google Scholar]
  3. Eberli F. R., Weinberg E. O., Grice W. N., Horowitz G. L., Apstein C. S. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res. 1991 Feb;68(2):466–481. doi: 10.1161/01.res.68.2.466. [DOI] [PubMed] [Google Scholar]
  4. Fath-Ordoubadi F., Beatt K. J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997 Aug 19;96(4):1152–1156. doi: 10.1161/01.cir.96.4.1152. [DOI] [PubMed] [Google Scholar]
  5. Malmberg K., Rydén L., Efendic S., Herlitz J., Nicol P., Waldenström A., Wedel H., Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995 Jul;26(1):57–65. doi: 10.1016/0735-1097(95)00126-k. [DOI] [PubMed] [Google Scholar]
  6. Mehta Shamir R., Yusuf Salim, Díaz Rafael, Zhu Jun, Pais Prem, Xavier Denis, Paolasso Ernesto, Ahmed Rashid, Xie Changchun, Kazmi Khawar. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005 Jan 26;293(4):437–446. doi: 10.1001/jama.293.4.437. [DOI] [PubMed] [Google Scholar]
  7. Opie L. H., Bruyneel K., Owen P. Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon. Circulation. 1975 Jul;52(1):49–57. doi: 10.1161/01.cir.52.1.49. [DOI] [PubMed] [Google Scholar]
  8. Rackley C. E., Russell R. O., Jr, Rogers W. J., Mantle J. A., McDaniel H. G. Glucose-insulin-potassium infusion in acute myocardial infarction. Review of clinical experience. Postgrad Med. 1979 Feb;65(2):93–99. doi: 10.1080/00325481.1979.11715053. [DOI] [PubMed] [Google Scholar]
  9. SODI-PALLARES D., TESTELLI M. R., FISHLEDER B. L., BISTENI A., MEDRANO G. A., FRIEDLAND C., DE MICHELI A. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol. 1962 Feb;9:166–181. doi: 10.1016/0002-9149(62)90035-8. [DOI] [PubMed] [Google Scholar]

Articles from Netherlands Heart Journal are provided here courtesy of Springer

RESOURCES